OrthoPediatrics Corp. (KIDS)
| Market Cap | 1.15B |
| Revenue (ttm) | 106.24M |
| Net Income (ttm) | -11.56M |
| Shares Out | 20.28M |
| EPS (ttm) | -0.78 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 153,163 |
| Open | 54.60 |
| Previous Close | 55.06 |
| Day's Range | 53.90 - 56.67 |
| 52-Week Range | 36.71 - 73.91 |
| Beta | 0.88 |
| Analysts | Buy |
| Price Target | 60.69 (+7.1%) |
| Earnings Date | Aug 3, 2022 |
About KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking can... [Read more...]
Financial Performance
In 2021, KIDS's revenue was $98.05 million, an increase of 37.95% compared to the previous year's $71.08 million. Losses were -$16.26 million, -50.64% less than in 2020.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is 60.69, which is an increase of 7.09% from the latest price.
News
OrthoPediatrics Corp. Announces Closing of its Public Offering of Common Stock and Pre-Funded Warrants and Full Exerc...
WARSAW, Ind., Aug. 15, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants
WARSAW, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -13.33% and 0.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
Second Quarter 2022 Record Revenue Increased 23% Year-over-Year Second Quarter 2022 Record Adjusted EBITDA of $2.1 million
2022 Roundtable: Our Favorite Picks Right Now
Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.
OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022
WARSAW, Ind., July 21, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...
OrthoPediatrics Corp. Completes Acquisition of Pega Medical
WARSAW, Ind., July 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
Buy the Dip on These 3 Healthcare Stocks
Here's why our roundtable likes Vir Biotechnology, OrthoPediatrics, and Vertex Pharmaceuticals.
OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical
Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System™ Expands portfolio of trauma and deformity systems for pediatric orthopedics...
OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
WARSAW, Ind., May 24, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 0% and 3.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
First Quarter 2022 Revenue Increased 9% Year-over-Year First Quarter 2022 Revenue Increased 9% Year-over-Year
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022
WARSAW, Ind., April 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today ...
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These companies have a history of creating shareholder value -- and still have plenty of room for growth.
OrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics
Expands portfolio with a patented, non-operative solution for the treatment of clubfoot Expands portfolio with a patented, non-operative solution for the treatment of clubfoot
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 17.24% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
OrthoPediatrics Corp. Reports Fourth Quarter and Record Full Year 2021 Financial Results
Fourth Quarter 2021 Revenue Increased 31% Year-over-Year 2021 Revenue Increased 38% Year-over-Year
OrthoPediatrics Corp. Named One of the 2022 Best Places to Work in Indiana
WARSAW, Ind., Feb. 25, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, ...
OrthoPediatrics (KIDS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OrthoPediatrics Corp. Celebrates 1,000th Case with FIREFLY® Pedicle Screw Navigation Guides
Company's partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatment Company's partnership with Mighty Oak Medical for 3D printed, ...
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
WARSAW, Ind., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...
OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021
WARSAW, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...
Telos Partners LLC Welcomes Industry Veteran Scott Day as Senior VP and General Manager to Accelerate Growth Strategy
WARSAW, Ind.--(BUSINESS WIRE)-- #MDR--Telos Partners LLC, a subsidiary of OrthoPediatrics Corporation (NASDAQ: KIDS), specializing in the delivery of regulatory, reimbursement, and clinician adoption an...
3 Last-Minute Healthcare Stocking Stuffers
Here are three stocks sure to pique the interest of that special someone.
OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support as a ...